Results 151 to 160 of about 5,747 (197)
Immunoproteasome inhibition triggers protein stress and apoptosis in cells of B cell lineage without impairing vaccination-induced antibody responses. [PDF]
Mink D +7 more
europepmc +1 more source
Chronic IFN-γ Exposure Induces Divergent Adaptive Programs in Glioblastoma Subtypes. [PDF]
Rahbarlayegh E +4 more
europepmc +1 more source
The immunoproteasome regulates ILC2 responses by modulating mitochondrial capacity. [PDF]
Laurent P +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Immunoproteasomes and immunosenescence
Ageing Research Reviews, 2003Aging is a complex process which is accompanied with the decline and the reshaping of different functions of the body. In particular the immune system is characterized, during ageing (immunosenescence) by a remodeling of innate immunity (well preserved, up-regulated) and clonotypical immunity (severely altered) and by the occurrence of a chronic ...
Mishto M. +5 more
openaire +3 more sources
Proteasomes and immunoproteasomes.
Rivista di biologia, 2011In eukaryotic cells, the protein degradation is a highly regulated and selective process. Membrane-associated or extracellular proteins are degraded in lysosomes, whereas intracellular protein dismantling is primarily non-lysosomal, being realized by complex, not-membrane enclosed and energy-dependent effectors, the proteasomes, localized in both ...
Fietta, Pieranna, Delsante, Giovanni
openaire +2 more sources
American Journal of Transplantation, 2017
Modern treatment strategies for the maintenance of allograft acceptance frequently target ubiquitously-expressed pathways, leading to significant side-effects and poor long-term allograft outcomes. Constitutive proteasome inhibitors, which have recently been introduced for the treatment of antibody-mediated rejection, target the ubiquitously-expressed ...
Eskandari, S. K. +3 more
openaire +1 more source
Modern treatment strategies for the maintenance of allograft acceptance frequently target ubiquitously-expressed pathways, leading to significant side-effects and poor long-term allograft outcomes. Constitutive proteasome inhibitors, which have recently been introduced for the treatment of antibody-mediated rejection, target the ubiquitously-expressed ...
Eskandari, S. K. +3 more
openaire +1 more source
A patent review of immunoproteasome inhibitors
Expert Opinion on Therapeutic Patents, 2018The ubiquitin-proteasome system is responsible for maintaining protein homeostasis and regulating a variety of cellular processes. The constitutive proteasome is expressed in all cells while the immunoproteasome (IP) is predominantly found in cells of hematopoietic origin.
Eva, Ogorevc +3 more
openaire +2 more sources
Immunoproteasome as a Target for Prodrugs
Journal of Medicinal ChemistryImmunoproteasome (iCP) is a proteasome isoform that is expressed under inflammatory conditions such as cytokine interferon-γ exposure. The iCP has different catalytic subunits other than the standard CP (standard core particle), allowing the production of major histocompatibility complex class I (MHC-I) compatible peptides for eventual T-cell ...
Christine S. Muli +2 more
openaire +2 more sources
Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension
2023SUMMARY Abstract Figure Graphical Abstract Isolevuglandins (isoLGs) are lipid aldehydes that form in the presence of reactive oxygen species (ROS) and drive immune activation.
Néstor de la Visitación +10 more
openaire +2 more sources
Emerging role of immunoproteasomes in pathophysiology
Immunology & Cell Biology, 2016The immunoproteasome is a proteasome variant that is found only in jawed vertebrates. It is responsible for degrading intracellular proteins to generate a major source of peptides with substantial major histocompatibility complex I binding affinity. The immunoproteasome also has roles in T‐cell survival, differentiation and proliferation in various ...
Gagandeep, Kaur, Sanjay, Batra
openaire +2 more sources

